英国皇家医师学院(RCP)发布的调查报告指出,大学医院考文垂和华威郡 NHS 信托基金在脑肿瘤患者的治疗中存在严重的医疗管理不当 1。此次审查涵盖了20名脑肿瘤病例,结果显示其中15人的护理质量令人不满意,另有5人需进行改进 1。
报告揭示的核心问题涉及长期重复使用化疗药物替莫唑胺(TMZ),这种治疗方案远超常规疗程且缺乏证据表明患者从中受益 1。一名患者被误诊为胶质母细胞瘤并接受了超过10年的化疗,而实际诊断仅为低级别毛细胞型星形细胞瘤 1。另一名患者 Becky Jones 在被告知仅剩6至12个月寿命的情况下,于10年内接受了超过100个周期的化疗,尽管其扫描结果保持稳定 1。
涉事医生 Ian Brown 教授已于2023年退休,调查是由其前同事提出关切后启动的 1。该信托基金首席执行官 Andy Hardy 和主席 Sue Noyes 已就此发表道歉声明 1。代表40多名患者的律师事务所 Brabners 正呼吁对该事件展开独立公开调查 1。
A report released by the Royal College of Physicians (RCP) has exposed serious clinical failings at University Hospitals Coventry and Warwickshire NHS trust, revealing that cancer patients endured years of unnecessary chemotherapy. 1 The review identified that many brain tumor patients were subjected to prolonged treatment with temozolomide (TMZ), a regimen that far exceeded standard protocols and offered no evidence of benefit. 1
The investigation examined the care of 20 brain tumor patients, concluding that 15 received inadequate care while another five required improvements in their treatment plans. 1 In one severe case, a patient was misdiagnosed with glioblastoma and received chemotherapy for more than ten years, only to be later diagnosed with a low-grade pilocytic astrocytoma. 1 Another patient, Becky Jones, underwent over 100 cycles of chemotherapy within a decade after being told she had only six to twelve months to live, despite scans showing her condition remained stable. 1
These failures have drawn attention to Professor Ian Brown, who retired from the trust in 2023 after former colleagues raised concerns that triggered the inquiry. 1 In response to the findings, trust Chief Executive Andy Hardy and Chair Sue Noyes have issued formal apologies for the harm caused. 1 Meanwhile, Brabners, a law firm representing more than 40 affected patients, is calling for an independent public inquiry into the incident. 1
评论
还没有评论,欢迎留下第一条。